CDC Shift on Covid Vaccines Creates Coverage Uncertainty for Americans
Most Americans with health insurance will likely continue to have access to no-cost Covid-19 vaccines, but a recent change in federal guidance has introduced ambiguity regarding insurance coverage, potentially leading to out-of-pocket costs for some. The US Centers for Disease Control and Prevention (CDC) has moved away from a broad recommendation for Covid-19 immunization, now requiring individuals to consult with a healthcare provider – a process known as shared clinical decision-making – to receive the shot.
The shift stems from a vote by the CDC’s vaccine advisors and has raised concerns among experts that insurers may no longer be obligated to fully cover the cost of the immunization, which can reach approximately $140 per dose. While a prescription is not necessarily required, the change in recommendation has sparked debate over whether the Affordable Care Act (ACA) mandates will continue to apply.
The ACA requires most private insurers to cover vaccines recommended by the CDC’s Advisory Committee on Immunization Practices (ACIP) at no cost to the patient. Similarly, Medicaid’s no-cost vaccine coverage is also linked to ACIP recommendations. Importantly, Medicare is legally required to cover the Covid-19 vaccine without cost-sharing, and remains unaffected by the recent changes.
A spokesperson from the US Department of Health and Human Services stated last month that the CDC committee’s vote “provides for immunization coverage through all payment mechanisms including entitlement programs such as Children’s Health Insurance Program, Medicaid, and Medicare, as well as insurance plans through the federal Health Insurance Marketplace.” However, experts caution that the situation is not entirely straightforward.
“Insurers may not unanimously agree that they have to cover vaccines with shared decision-making recommendations at no cost,” said Amy Killelea, an assistant research professor at Georgetown University’s Center on Health Insurance Reforms. She explained that the CDC has attempted to clarify that shared decision-making recommendations should still fall under the ACA mandate, but this clarification has injected “ambiguity” into the extent of coverage.
The regulatory landscape further complicates the issue. Many private insurance plans are overseen by the Departments of Health and Human Services, Labor, and Treasury, none of which have yet issued guidance on shared decision-making. Other plans are regulated at the state level, with at least 13 states already taking steps to require insurers to continue providing Covid-19 vaccines for free, according to KFF, a nonpartisan health policy research group.
Despite the uncertainty, major insurers have signaled their intention to maintain current coverage levels. AHIP, the nation’s largest trade association for health insurers representing over 200 million Americans, stated that its members will not alter coverage for policyholders through the end of 2026. In a statement released prior to the September ACIP meeting, AHIP affirmed its commitment to covering all immunizations recommended as of September 1 at no cost, including the updated Covid-19 vaccine.
“Health plans are committed to maintaining and ensuring affordable access to vaccines,” the association stated, adding that shared decision-making recommendations must be covered without cost-sharing. Their coverage decisions are based on “ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.”
UnitedHealthcare, the nation’s largest insurer and a non-member of AHIP, echoed this sentiment, announcing full coverage of ACIP-recommended Covid-19 vaccines in its standard commercial plans as of January 1. However, the company advised individuals with job-based policies to verify coverage with their employers. “UnitedHealthcare is committed to enabling access to safe, effective and affordable care, including coverage for vaccinations,” the company stated, emphasizing the importance of discussing vaccination with healthcare providers.
Blue Cross Blue Shield insurers will also cover all vaccines recommended by the committee as of January 1 with no cost to patients through the end of next year, operating within existing federal and state laws, according to the Blue Cross Blue Shield Association.
Despite these assurances, some insurers could still attempt to argue they are not mandated to cover the full cost of the Covid-19 vaccine. “There’s nothing that requires insurers to cover vaccines not recommended by ACIP at no cost,” Killelea noted. “Where it could be ambiguous is whether all insurers will view a shared decision-making recommendation as a full recommendation from ACIP.” Medicaid enrollees, however, will continue to receive the vaccine at no cost, consistent with earlier guidance from the Centers for Medicare and Medicaid Services.
Beyond Covid-19, the CDC advisory committee also altered recommendations regarding the combined measles, mumps, rubella, and varicella (MMRV) vaccine. The committee voted to no longer recommend the MMRV vaccine before age 4, meaning private insurers are no longer required to cover it at no cost. This could result in parents facing out-of-pocket expenses if they choose the combined vaccine, and vaccine manufacturers may discontinue production. The MMRV vaccine will also no longer be automatically covered by Medicaid and the Children’s Health Insurance Program, although states retain the option to continue coverage. The separate vaccines for measles, mumps, rubella, and varicella will remain recommended and covered at no cost.
The evolving landscape of vaccine coverage underscores the importance of proactive communication between patients, healthcare providers, and insurance companies to ensure continued access to vital immunizations.
Worth a look
